13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001213900-25-075901
Total Value
$977.1M
Positions
42
Other Managers
0
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 3,958,294 | $331.6M | 33.94% |
| 2 | Verona Pharma PLC | 925050106 | 1,393,432 | $131.8M | 13.49% |
| 3 | Cidara Therapeutics, Inc. | 171757206 | 1,311,425 | $63.9M | 6.54% |
| 4 | Geron Corp | GERN | 27,225,292 | $38.4M | 3.93% |
| 5 | Sinovac Biotech Ltd. | SVA | 5,903,000 | $38.2M | 3.91% |
| 6 | Oric Pharmaceuticals Inc | ORIC | 3,126,604 | $31.7M | 3.25% |
| 7 | Terns Pharmaceuticals Inc | TERN | 6,895,746 | $25.7M | 2.63% |
| 8 | Trevi Therapeutics Inc | TRVI | 4,487,903 | $24.5M | 2.51% |
| 9 | Avadel Pharmaceuticals PLC | G29687103 | 2,684,109 | $23.8M | 2.43% |
| 10 | Akero Therapeutics Inc | 00973Y108 | 434,689 | $23.2M | 2.37% |
| 11 | Compass Therapeutics Inc | CMPX | 6,043,466 | $15.7M | 1.61% |
| 12 | Viridian Therapeutics Inc | VRDN | 982,576 | $13.7M | 1.41% |
| 13 | Cytomx Therapeutics Inc | CTMX | 5,769,230 | $13.1M | 1.34% |
| 14 | Aclaris Therapeutics, Inc. | ACRS | 8,888,888 | $12.6M | 1.29% |
| 15 | Zenas Biopharma Inc | ZBIO | 1,183,260 | $11.5M | 1.17% |
| 16 | Dyne Therapeutics Inc | DYN | 1,114,960 | $10.6M | 1.09% |
| 17 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $10.5M | 1.07% |
| 18 | DBV Technologies SA | DBVTF | 1,054,506 | $9.7M | 0.99% |
| 19 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $9.5M | 0.97% |
| 20 | Rezolute Inc | RZLT | 2,112,432 | $9.4M | 0.96% |
| 21 | Compass Pathway PLC | CMPS | 3,362,385 | $9.4M | 0.96% |
| 22 | Corvus Pharmaceuticals Holdings | CRVS | 2,234,566 | $8.9M | 0.91% |
| 23 | IO Biotech Inc | IOBT | 6,173,439 | $8.6M | 0.88% |
| 24 | Erasca Inc | ERAS | 6,756,756 | $8.6M | 0.88% |
| 25 | Astria Therapeutics Inc | 04635X102 | 1,552,685 | $8.3M | 0.85% |
| 26 | Celcuity Inc | CELC | 610,500 | $8.2M | 0.83% |
| 27 | Cogent Biosciences Inc | COGT | 1,122,471 | $8.1M | 0.82% |
| 28 | Delcath Systems, Inc. | DCTH | 569,526 | $7.7M | 0.79% |
| 29 | Praxis Precision Medicines | PRAX | 167,600 | $7.0M | 0.72% |
| 30 | Bright Minds Biosciences Inc | DRUG | 251,572 | $6.6M | 0.67% |
| 31 | Olema Pharmaceuticals Inc | OLMA | 1,505,862 | $6.4M | 0.66% |
| 32 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $6.4M | 0.66% |
| 33 | Verastem Inc | VSTM | 1,538,461 | $6.4M | 0.65% |
| 34 | Instil Bio Inc | TIL | 292,743 | $6.1M | 0.62% |
| 35 | Unicycive Therapeutics | UNCY | 1,137,015 | $5.4M | 0.56% |
| 36 | Sera Prognostics Inc | SERA | 1,650,440 | $4.6M | 0.47% |
| 37 | 89Bio Inc | 282559103 | 376,804 | $3.7M | 0.38% |
| 38 | Tango Therapeutics Inc | TNGX | 600,000 | $3.1M | 0.31% |
| 39 | Surrozen Inc | SRZNW | 260,000 | $2.3M | 0.24% |
| 40 | Tenax Therapeutics Inc | TENX | 208,333 | $1.2M | 0.12% |
| 41 | Bolt Therapeutics Inc | BOLT | 176,064 | $985,958 | 0.10% |
| 42 | Precision Biosciences Inc | DTIL | 4,675 | $19,636 | 0.00% |